B CELLS AND ACQUIRED T CELL IMMUNITY
B CELLS AND ACQUIRED T CELL IMMUNITY
批准号:
2902521
负责人:
PHILIP William ASKENASE
金额:
$26.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2001-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We recently found a role for complement (C) in delayed-type hypersensitivity (DTH), and in contact sensitivity (CS). This led to our finding a role for B cells. Now we will investigate B cell subsets and Ig isotypes that are involved. The B-1 B cell subset likely plays a role by secreting IgM, that may activate C, possibly leading to local T cell recruitment, especially early after sensitization (1-4 days). We also will explore B-2 cell IgG2a and IgG2b C-activating antibodies, and B cell APC function. SPECIFIC AIM #1. To identify needed B cell subsets. FACS purified normal B-1 vs B-2 cells will be transferred into pan B-cell deficient JH-/- mice. To determine if reconstituting B cells act at the elicitation phase, we also will transfer immune B cell subsets into already sensitized JH-/- mice, and then challenge the skin. Radiation chimeras that express dominant B-1 vs B-2 cells, also will be used. SPECIFIC AIM #2. Determine properties of B cells in CS. If B-1 cells are preferentially involved, we will determine if they are Thy-1+, that may be induced via an early release of IL-4 from activated NK 1.1+ cells, and activated B-1 cells may possibly migrate from peritoneum to lymph nodes, and potentially have diverse V regions, and higher Ag affinity. SPECIFIC AIM #3. Determine how B cells function in CS. APC function will be explored in mutant mice with Ig+ B cells, but no secreted Ig. The possible involvement of IgM will be determined by employing mutant mice that just lack secreted IgM. If they are deficient in CS, we will attempt reconstitution with purified IgM mAb. More definitively, we will create transgenes in JH-/- of relevant specific Ig isotypes, to attempt CS-reconstitution. Finally, we will use anti-TNP IgM mutant hybridoma lines, to determine which amino acid residues in the Fc portion are essential for DTH. IN SUMMARY. Our experiments will determine the B cell subset(s) and Ig isotype(s) involved in DTH, and whether B cells act in the afferent, and/or the elicitation phase. Unique participation of B-1 cells is postulated, as one part of B cell involvement. These studies bring new ideas about antibodies acting in eliciting T cell immunity, and may uniquely connect innate immunity (C), with acquired T cell immunity (DTH), via linkage provided by natural immunity (B-1 cell IgM). Since DTH is central to in vivo T cell reactivity, these studies may be important to an indepth understanding of T cell diseases and immune resistance, and thus may have wide applicability to human health.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Endothelial cell E- and P-selectin up-regulation in murine contact sensitivity is prolonged by distinct mechanisms occurring in sequence.
小鼠接触敏感性中内皮细胞 E-和 P-选择素的上调通过依次发生的不同机制而延长。
DOI:
--
发表时间:
1999
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Harari,OA, McHale,JF, Marshall,D, Ahmed,S, Brown,D, Askenase,PW, Haskard,DO]
通讯作者:
Haskard,DO
IL-12 reverses established tolerance mediated by TCRalphabeta+ but not by TCRgammadelta+ suppressor T cells.
IL-12 可逆转 TCRalphabeta 介导的耐受性,但不能逆转 TCRgammadelta 抑制性 T 细胞介导的耐受性。
DOI:
10.3109/08820130009060865
发表时间:
2000
期刊:
Immunological investigations
影响因子:
2.8
作者:
[Szczepanik,M, Askenase,PW]
通讯作者:
Askenase,PW
The Role of AID in Contact Sensitivity
-
批准号:7847588
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2009
-
负责人:PHILIP William ASKENASE
-
依托单位:
The Role of AID in Contact Sensitivity
-
批准号:7347659
-
项目类别:
-
资助金额:$24.83万
-
财政年份:2009
-
负责人:PHILIP William ASKENASE
-
依托单位:
Initiation of Contact and Asthmatic Hypersensitivity
-
批准号:7183609
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2004
-
负责人:PHILIP William ASKENASE
-
依托单位:
Initiation of Contact and Asthmatic Hypersensitivity
-
批准号:7023890
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2004
-
负责人:PHILIP William ASKENASE
-
依托单位:
Initiation of Contact and Asthmatic Hypersensitivity
-
批准号:7367191
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2004
-
负责人:PHILIP William ASKENASE
-
依托单位:
Initiation of Contact and Asthmatic Hypersensitivity
-
批准号:6861027
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2004
-
负责人:PHILIP William ASKENASE
-
依托单位:
Initiation of Contact and Asthmatic Hypersensitivity
-
批准号:6759076
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2004
-
负责人:PHILIP William ASKENASE
-
依托单位:
INITIATOR T CELLS IN DELAYED-TYPE HYPERSENSITIVITY
-
批准号:3140567
-
项目类别:
-
资助金额:$16.5万
-
财政年份:1989
-
负责人:PHILIP William ASKENASE
-
依托单位:
INITIATOR CELLS IN DELAYED-TYPE HYPERSENSITIVITY
-
批准号:2063492
-
项目类别:
-
资助金额:$25.59万
-
财政年份:1989
-
负责人:PHILIP William ASKENASE
-
依托单位:
INITIATOR CELLS IN DELAYED-TYPE HYPERSENSITIVITY
-
批准号:2063491
-
项目类别:
-
资助金额:$24.49万
-
财政年份:1989
-
负责人:PHILIP William ASKENASE
-
依托单位:
INITIATOR T CELLS IN DELAYED-TYPE HYPERSENSITIVITY
-
批准号:3140566
-
项目类别:
-
资助金额:$15.87万
-
财政年份:1989
-
负责人:PHILIP William ASKENASE
-
依托单位:
INITIATOR T CELLS IN DELAYED-TYPE HYPERSENSITIVITY
-
批准号:3140564
-
项目类别:
-
资助金额:$17.37万
-
财政年份:1989
-
负责人:PHILIP William ASKENASE
-
依托单位:
INITIATOR CELLS IN DELAYED-TYPE HYPERSENSITIVITY
-
批准号:2063493
-
项目类别:
-
资助金额:$26.65万
-
财政年份:1989
-
负责人:PHILIP William ASKENASE
-
依托单位:
INITIATOR T CELLS IN DELAYED-TYPE HYPERSENSITIVITY
-
批准号:3140565
-
项目类别:
-
资助金额:$24.43万
-
财政年份:1989
-
负责人:PHILIP William ASKENASE
-
依托单位:
INITIATOR CELLS IN DELAYED-TYPE HYPERSENSITIVITY
-
批准号:3140568
-
项目类别:
-
资助金额:$24.49万
-
财政年份:1989
-
负责人:PHILIP William ASKENASE
-
依托单位:
BASOPHIL HYPERSENSITIVITY AND IMMUNE HOST RESISTANCE
-
批准号:3127272
-
项目类别:
-
资助金额:$19.74万
-
财政年份:1981
-
负责人:PHILIP William ASKENASE
-
依托单位:
BASOPHIL HYPERSENSITIVITY AND IMMUNE HOST RESISTANCE
-
批准号:3127271
-
项目类别:
-
资助金额:$16.77万
-
财政年份:1981
-
负责人:PHILIP William ASKENASE
-
依托单位:
ALLERGY AND IMMUNOLOGY TRAINING GRANT
-
批准号:2671509
-
项目类别:
-
资助金额:$13.08万
-
财政年份:1980
-
负责人:PHILIP William ASKENASE
-
依托单位:
ALLERGY AND IMMUNOLOGY TRAINING GRANT
-
批准号:6152234
-
项目类别:
-
资助金额:$15.97万
-
财政年份:1980
-
负责人:PHILIP William ASKENASE
-
依托单位:
ALLERGY AND IMMUNOLOGY
-
批准号:3530940
-
项目类别:
-
资助金额:$11.61万
-
财政年份:1980
-
负责人:PHILIP William ASKENASE
-
依托单位:
海外基金